72
BROMME D, KIRSCHKE H. N-peptidyl-O-carbamoyl amino acid hydroxamates:
irreversible inhibitors for the study of the S2' specificity of cysteine proteinases. FEBS Lett.
v.322, n.3, p.211-214, 1993.
BRÖMME D, LI Z, BARNES M, MEHLER E. Human cathepsin V functional expression,
tissue distribution, electrostatic surface potential, enzymatic characterization, and
chromosomal localization. Biochemistry
. v.38 n.8 p.2377-2385, 1999.
BUCK, M.R., KARUTIS, D.G., DAY, N.A., HONN, K.V., E SOLANE, B.,F. Degradation of
extrcellular-matrx proteins by human cathepsin B from normal and tumor tissues. Biochem J
.
v.282, p.273-278, 1992.
BÜHLING F, WALDBURGN, REISENAUER A, HEIMBURG A., GOLPON H. E WELTE
T. Lysosomal cysteine proteases in the lung: role in protein processing and
immunoregulation. Eur Respir J v.23, p.620-628, 2004.
CARMONA, E., DUFOUR, E., PLOUFFE, C., TAKEBE, S., MANSON, P., MORT, J. S., E
MENARD, R. Potency and selectivity of the cathepsin L propetide as an inhibitor of cysteine
proteases. Biochemistry v.35, p.8149-8157, 1996.
CATALDO, A. M. HAMILTON, D. J. E NIXON, R. A. Lysosomal abnormalities in
degenerating neurons link neuronal compromise to senile plaque development in Alzheimer
disease. Brain Res
. v. 640, n.1-2, p.68-80, 1994.
COAKLEY, R.. J., TAGGART C., MCEVALNEY N. G., O’NEILL S. J., Cytosolic pH and
the inflammatory microenvironment modulate cell death in human neutrophils after
phagocytosis Blood v. 100 n. 9 p. 3383-3391, 2002